Talaromycosis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Liposomal Amphotericin B 3–5 mg/kg daily for 2 weeks induction, then Itraconazole 200 mg BD for 10 weeks maintenance
Talaromycosis (formerly penicilliosis) is a systemic mycosis caused by Talaromyces marneffei, endemic to South-East Asia (Thailand, Vietnam, southern China). It occurs almost exclusively in advanced HIV (CD4 <100). Umbilicated papulonodular skin lesions (resembling molluscum) are characteristic. Treatment follows a two-phase approach: induction with Liposomal Amphotericin B (or IV Amphotericin B deoxycholate) for 2 weeks, then consolidation with Itraconazole 200 mg BD for 10 weeks. Secondary prophylaxis with Itraconazole 200 mg daily continues until immune reconstitution.
Reference: BHIVA 2022 – OI guidelines; WHO 2021 – Talaromycosis